Infliximab 40.0 mg/mL Drug Substance
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67643-0012 -
Package NDC
67643-0012-1 -
Package NDC
67643-0012-2 -
SPL ID
458d5bbe-ca1e-8171-e063-6294a90a09e1
What the source publishes
- Labeler
- Lonza Biologics, Inc.
- Active ingredients
- Infliximab 40.0 mg/mL Drug Substance
- Form
- LIQUID
- Administrative status
- present-in-source-snapshot
- Marketing status
- DRUG FOR FURTHER PROCESSING
- Product type
- DRUG FOR FURTHER PROCESSING
Names this record is found by
Complete source data
{
"name": "Infliximab 40.0 mg/mL Drug Substance",
"splId": "458d5bbe-ca1e-8171-e063-6294a90a09e1",
"labels": [],
"routes": [],
"labeler": "Lonza Biologics, Inc.",
"finished": false,
"packaging": [
{
"description": "1000 mL in 1 BOTTLE (67643-0012-1)",
"package_ndc": "67643-0012-1",
"identifierStatus": "well-formed",
"marketing_start_date": "21-AUG-24"
},
{
"description": "10000 mL in 1 BOTTLE (67643-0012-2)",
"package_ndc": "67643-0012-2",
"identifierStatus": "well-formed",
"marketing_start_date": "21-AUG-24"
}
],
"productId": "67643-0012_458d5bbe-ca1e-8171-e063-6294a90a09e1",
"useDomain": "unknown",
"dosageForm": "LIQUID",
"productNdc": "67643-0012",
"deaSchedule": null,
"genericName": "Infliximab 40.0 mg/mL Drug Substance",
"productType": "DRUG FOR FURTHER PROCESSING",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INFLIXIMAB (REMICADE)",
"strength": "40 mg/mL"
}
],
"applicationNumber": null,
"marketingCategory": "DRUG FOR FURTHER PROCESSING",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240821",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67643-0012_458d5bbe-ca1e-8171-e063-6294a90a09e1"